ORASURE TECHNOLOGIES INC (OSUR)
US68554V1089 - Common Stock
Wall Street Favorites: 3 Under-$10 Stocks With Strong Buy Ratings for April 2024
Of the 687 U.S.-listed under-$10 stocks, these three have the potential to reach double digits in the future.
Oversold Conditions For OraSure Technologies (OSUR)
OraSure Technologies Non-GAAP EPS of $0.22 beats by $0.11, revenue of $75.88M beats by $1.61M (NASDAQ:OSUR)
OraSure Technologies reported strong Q4 earnings with beating expectations in non-GAAP EPS and revenue.
OraSure Reports Q4 ‘23 Revenue of $75.9 Million
OraSure Reports Q4 ‘23 Revenue of $75.9 Million
Q4 GAAP EPS of $0.27; Q4 Non-GAAP EPS of $0.22 Grew cash balance to $290.4 million as of December 31, 2023 Enters U.S. Syphilis testing market via...
Oversold Conditions For OraSure Technologies (OSUR)
OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th
OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th
BETHLEHEM, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering...
Commit To Purchase OraSure Technologies At $5, Earn 6.7% Annualized Using Options
OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company
OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company
The relationship expands OraSure’s innovation pipeline with access to a broad portfolio of key Sapphiros products in development. Distribution of...
OraSure to Participate in Upcoming Investor Conferences
OraSure to Participate in Upcoming Investor Conferences
BETHLEHEM, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests,...
7 Healthcare Stocks That Are Poised to Become the Next Unicorns
Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.
Commit To Purchase OraSure Technologies At $5, Earn 20.2% Annualized Using Options
OraSure Technologies Non-GAAP EPS of $0.27 beats by $0.19, revenue of $89.19M beats by $14.62M (NASDAQ:OSUR)
OraSure Technologies beats Q3 earnings and revenue expectations.
OraSure Reports Q3 ‘23 Revenue of $89.2 Million; Core Revenue Grows 7% Year-over-Year
OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th
OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th
BETHLEHEM, Pa., Oct. 23, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering...
OraSure Technologies (OSUR) Shares Cross Below 200 DMA
OraSure Technologies Breaks Below 200-Day Moving Average - Notable for OSUR
Commit To Buy OraSure Technologies At $5, Earn 19.6% Annualized Using Options
OraSure up 31% on Q3 revenue outlook, Q2 results (NASDAQ:OSUR)
OraSure Technologies is up ~31% Friday after issuing Q3 2023 revenue guidance that is well above the consensus and easily beating Q2 estimates. Read more here.
OraSure Reports Q2 ‘23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year
OraSure Reports Q2 ‘23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year
InteliSwab® test revenue of $47.5 million in Q2 Q2 Core revenue of $37.9 million grew 4% sequentially and 3% year-over-year Q2 GAAP EPS of...